NASDAQ:ALT
Altimmune, Inc. Stock News
$7.19
+0.120 (+1.70%)
At Close: May 02, 2024
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) * Arcutis Biotherapeutics Inc (NASDAQ: ARQT) * A
NVAX, INO among premarket gainers
02:14pm, Friday, 06'th Mar 2020
Digirad (NASDAQ:DRAD) +63% on Q4 results.Enzo Biochem (NYSE:ENZ) +50% on launch of coronavirus testing service.NanoViricides (NYSEMKT:NNVC) +34% on coronavirus drug progress.TEGNA (NYSE:TGNA) +28%�
Healthcare dominates premarket losers amidst coronavirus situation
02:23pm, Tuesday, 03'rd Mar 2020
Spherix (NASDAQ:SPEX) -25%.Dynatronics (NASDAQ:DYNT) -22%.China Pharma Holdings (NYSEMKT:CPHI) -19%.Co-Diagnostics (NASDAQ:CODX) -17%.Tilray (NASDAQ:TLRY) -14% on Q4 earnings.Cleveland BioLabs (NAS
This local bio wants to swiftly deliver a coronavirus vaccine. It will need some help.
08:12pm, Monday, 02'nd Mar 2020
Gaithersburg’s Altimmune is working on a vaccine for the COVID-19 coronavirus.
Company News for Mar 2, 2020
03:15pm, Monday, 02'nd Mar 2020
Companies in the news are: ALT, BIG, W, CDXS
Stocks To Watch: Time For Coronavirus Offense Or Defense?
01:26pm, Saturday, 29'th Feb 2020
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive th
Mid-Afternoon Market Update: Dow Tumbles Over 900 Points; Beyond Meat Shares Plunge On Earnings Miss
07:30pm, Friday, 28'th Feb 2020
Toward the end of trading Friday, the Dow traded down 3.53% to 24856.01 while the NASDAQ fell 2.29% to 8370.04. The S&P also fell, dropping 2.97% to 2890.26. Coronavirus cases...
NVAX, SGMO among premarket gainers
02:20pm, Friday, 28'th Feb 2020
Dynatronics (NASDAQ:DYNT) +224%.Altimmune (NASDAQ:ALT) +143% on completing first development milestone toward a single-dose intranasal COVID-19 vaccine.Allied Healthcare Products (NASDAQ:AHPI) +103%
Altimmune Completes First Development Milestone Toward a Single-Dose Intranasal COVID-19 Vaccine
12:00pm, Friday, 28'th Feb 2020
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company, today announced the advancement of a novel single-dose, intranasal vaccine using Altimmune’s proprietary technology to protect agai
Altimmune to Present at the Cowen 40th Annual Health Care Conference
09:30pm, Wednesday, 19'th Feb 2020
GAITHERSBURG, Md., Feb. 19, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that Vipin K. Garg, Ph.D., President and Chief.
Altimmune to Present at Upcoming Investor and Scientific Conferences
12:00pm, Tuesday, 04'th Feb 2020
GAITHERSBURG, Md., Feb. 04, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that management will present at the following.
The Wuhan Coronavirus: 21 Stocks to Watch
05:00pm, Wednesday, 29'th Jan 2020
News like the Coronavirus can affect the stock market — either as a whole or just certain stocks and sectors. See how you can prepare.
Altimmune Announces Positive Results for ALT-702 in Preclinical Model of Colorectal Cancer
12:00pm, Thursday, 23'rd Jan 2020
Altimmune, Inc. (ALT), a clinical-stage biopharmaceutical company today announced that the Company’s immuno-oncology product candidate, ALT-702, met a key pre-clinical efficacy milestone with the de
Altimmune to Present at the 2020 NASH-TAG Conference
01:43pm, Tuesday, 07'th Jan 2020
GAITHERSBURG, Md., Jan. 07, 2020 -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced an oral presentation at the 2020 NASH-TAG.
